Analysis of Clostridium difficile biofilms: imaging and antimicrobial treatment | Zendy

Garth A. James | Zendy; Laurent Chesnel | Zendy; Laura Boegli | Zendy; Elinor deLancey Pulcini | Zendy; Steve Fisher | Zendy; Philip S. Stewart | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Analysis of Clostridium difficile biofilms: imaging and antimicrobial treatment

Author(s) -

Garth A. James,

Laurent Chesnel,

Laura Boegli,

Elinor deLancey Pulcini,

Steve Fisher,

Philip S. Stewart

Publication year - 2017

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dkx353

Subject(s) - fidaxomicin , microbiology and biotechnology , metronidazole , clostridium difficile , biofilm , vancomycin , antibiotics , antimicrobial , spore , biology , bacteria , staphylococcus aureus , genetics

Clostridium difficile, a spore-forming Gram-positive anaerobic bacillus, is the most common causative agent of healthcare-associated diarrhoea. Formation of biofilms may protect C. difficile against antibiotics, potentially leading to treatment failure. Furthermore, bacterial spores or vegetative cells may linger in biofilms in the gut causing C. difficile infection recurrence.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research